GetTopicDetailResponse(id=f8b12e8561, topicName=ARTEMIS, introduction=ARTEMIS, content=null, image=null, comments=3, allHits=744, url=https://h5.medsci.cn/topic?id=2785, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=71529, tagList=[TagDto(tagId=71529, tagName=ARTEMIS)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1780034, encodeId=cdb71e800342d, content=<a href='/topic/show?id=f8b12e8561' target=_blank style='color:#2F92EE;'>#ARTEMIS#</a>, objectTitle=Cancer Cell：吳一龍，周清教授發(fā)現(xiàn)靶向聯(lián)合抗血管新生對(duì)EGFR突變NSCLC患者獲益顯著(ARTEMIS-CTONG1509研究）, objectType=article, longId=215743, objectId=7f20215e43ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f20215e43ec, replyNumber=0, likeNumber=102, createdTime=2022-05-09, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f20215e43ec, moduleTitle=Cancer Cell：吳一龍，周清教授發(fā)現(xiàn)靶向聯(lián)合抗血管新生對(duì)EGFR突變NSCLC患者獲益顯著(ARTEMIS-CTONG1509研究）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=7f20215e43ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780033, encodeId=ca871e80033c4, content=<a href='/topic/show?id=f8b12e8561' target=_blank style='color:#2F92EE;'>#ARTEMIS#</a>, objectTitle=ACC 2018：ARTEMIS研究：改善心肌梗死后患者的支付能力，可以提高醫(yī)生和患者的依從性, objectType=article, longId=132255, objectId=0f0d132255d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f0d132255d5, replyNumber=0, likeNumber=104, createdTime=2018-04-14, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f0d132255d5, moduleTitle=ACC 2018：ARTEMIS研究：改善心肌梗死后患者的支付能力，可以提高醫(yī)生和患者的依從性, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=0f0d132255d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1780032, encodeId=5cd01e8003288, content=<a href='/topic/show?id=f8b12e8561' target=_blank style='color:#2F92EE;'>#ARTEMIS#</a>, objectTitle=Lancet Oncol：貝伐單抗添加到新輔助化療對(duì)HER2陰性乳腺癌效果（ARTemis試驗(yàn)）, objectType=article, longId=50644, objectId=48375064403, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=48375064403, replyNumber=0, likeNumber=137, createdTime=2015-11-22, rootId=0, userName=pandamao2010, userId=d4b7363, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=48375064403, moduleTitle=Lancet Oncol：貝伐單抗添加到新輔助化療對(duì)HER2陰性乳腺癌效果（ARTemis試驗(yàn)）, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=48375064403)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
